CF PharmTech, Inc. — Proxy Solicitation & Information Statement 2026

Jun 2, 2026

CF PHARMTECH

优|简|档|盥

CF PharmTech, Inc.

長風藥業股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 2652)

Form of proxy for the Annual General Meeting to be held on Friday, June 26, 2026

Number of shares to which this form of proxy relates(Note 1)

I/We(Note 2),

of

being the shareholder(s) in the share capital of CF PharmTech, Inc. (the “Company”), hereby appoint(Note 3)

of

failing him/her, the Chairman of the meeting as my/our proxy to attend and vote on my/our behalf at the annual general meeting of the Company to be held at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC, on Friday, June 26, 2026 at 10:00 a.m. and at any adjournment of the meeting. I/We direct that my/our vote(s) be cast on the specified resolutions as indicated by an “,” in the appropriate boxes.

ORDINARY RESOLUTIONS		FOR(Note 4)	AGAINST(Note 4)	ABSTAIN(Note 4)
1.	To consider and approve the audited consolidated financial statements of the Company for the year ended December 31, 2025.
2.	To consider and approve the annual report of the Company for the year ended December 31, 2025.
3.	To consider and approve the:
	3.1 election of Dr. LIANG Bill Wenqing as executive Director for the Fourth Session of the Board.
	3.2 election of Dr. LI LI BOVET as executive Director for the Fourth Session of the Board.
	3.3 election of Dr. LI Qi as executive Director for the Fourth Session of the Board.
	3.4 election of Ms. ZHU Yuyu as executive Director for the Fourth Session of the Board.
	3.5 election of Ms. ZHANG Jingjing as executive Director for the Fourth Session of the Board.
	3.6 election of Mr. CAI Lei as non-executive Director for the Fourth Session of the Board.
	3.7 election of Dr. YI Hua as non-executive Director for the Fourth Session of the Board.
	3.8 election of Dr. JIN Jian as independent non-executive Director for the Fourth Session of the Board.
	3.9 election of Ms. WANG Lijuan as independent non-executive Director for the Fourth Session of the Board.
	3.10 election of Mr. WEI Shirong as independent non-executive Director for the Fourth Session of the Board.
3.11 election of Mr. IP Wang Hoi as independent non-executive Director for the Fourth Session of the Board.
4.	To consider and approve the:
	4.1 election of Ms. CHENG Xiangfeng as Supervisor for the Fourth Session of the Supervisory Committee.
	4.2 election of Ms. KUAI Jingjing as Supervisor for the Fourth Session of the Supervisory Committee.
	4.3 election of Mr. ZHENG Yao as Supervisor for the Fourth Session of the Supervisory Committee.
5.	To consider and approve the re-appointment of Ernst & Young as the auditor of the Company for a term until the conclusion of the next annual general meeting of the Company and to authorise the Board to determine its remuneration.
6.	To consider and approve the proposed amendments to the H Share Award Scheme to expand the scope of eligible participants to include service providers, and to authorize the Board and/or its delegatee to implement the amended H Share Award Scheme.
SPECIAL RESOLUTIONS		FOR(Note 4)	AGAINST(Note 4)	ABSTAIN(Note 4)
7.	To consider and approve the proposal regarding the grant of a general mandate to the Board to allot, issue and/or deal with (including any sale or transfer of treasury shares, if permitted under the Listing Rules) additional H shares of the Company not exceeding 20% of the total number of H shares of the Company in issue (excluding treasury shares), and to authorise the Board to make such amendments as it deems appropriate to the provisions of the articles of association of the Company, so as to reflect the new capital structure upon additional allotment and issuance of shares pursuant to such mandate.
8.	To grant a share repurchase mandate to the Board to repurchase shares of the Company not exceeding 10% of the total number of H shares of the Company in issue (excluding treasury shares).

Date:

Signature(Note 5):

---

Notes:

1. Please insert the number of shares and the class of shares to which this form of proxy relates. If no number is inserted, this form of proxy will be deemed to be related to all the shares of the company registered in your names.

2. Please insert full name(s) and address(es) in BLOCK CAPITALS as shown in the register of members of the Company. The names of all joint registered shareholders should be stated.

3. Please insert the name and address of the proxy. If no name is inserted, the Chairman of the Meeting will act as your proxy. A shareholder may appoint one or more proxies to attend the meeting and vote for him. The proxy need not be a member of the Company but must attend the meeting in person to represent you. Any alteration made to this proxy form must be initialled by the person who signs it.

4. IMPORTANT: IF YOU WISH TO VOTE FOR A RESOLUTION, PLEASE PUT A TICK (“,”) IN THE BOX MARKED “FOR”. IF YOU WISH TO VOTE AGAINST A RESOLUTION, PLEASE PUT A TICK (“,”) IN THE BOX MARKED “AGAINST”. IF YOU WISH TO VOTE ABSTENTION ON A RESOLUTION, PLEASE PUT A TICK (“,”) IN THE BOX MARKED “ABSTAIN”.

If no direction is given, your proxy may either vote or abstain at his/her discretion. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the AGM other than those referred to in the notice convening the AGM.

1. This form must be signed by you or your attorney duly authorised in writing or, in the case of a corporation, must be either executed under its common seal or under the hand of its legal representative, director(s) or duly authorised attorney(s) to it. ANY ALTERATION MADE TO THIS PROXY FORM MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.

2. Any abstention vote or waiver of voting shall be deemed as “abstain”. Blank, wrong, illegible or uncast votes shall be deemed as the voters’ waiver of their voting rights, and the voting results representing the shares held by such voters shall be counted as “abstain”. The abstention vote shall be regarded as valid votes when the Company counts the votes in respect of the relevant matter.

3. In case of joint holders, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of votes of the other joint holder(s) and for this purpose seniority will be determined by the order in which the names stand in the register of members of the Company.

4. To be valid, this form of proxy together with the notarized power of attorney or other authorization document (if any) must be deposited at the H share registrar of the Company, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Center, 183 Queen’s Road East, Wanchai, Hong Kong not less than 24 hours before the time appointed for the AGM. Completion and return of this form of proxy will not preclude a shareholder from attending and voting in person at the Meeting and any adjournment thereof if he/she so wishes. In such event, the instrument appointing a proxy shall be deemed to be revoked.

5. Shareholders or their proxies attending the Meeting (and any adjournment thereof) shall produce their identity documents.

6. Unless otherwise defined herein, capitalized terms used in this form shall have the same meanings as those defined in the circular of the Company dated June 2, 2026.